Diginex Faces Judgment Day: A Nasdaq Threat and a Stalled $1.5 Billion Deal

The clock has run out for Diginex on two fronts. The London-based ESG technology company must deliver an update by today on its long-pending acquisition of Resulticks Global Companies, while simultaneously fighting to keep its Nasdaq listing alive. For investors, the stakes could hardly be higher.

A Stock in Freefall

Diginex’s shares have been trading between $0.89 and $0.93, dangerously below the $1.00 minimum required by Nasdaq. The 52-week high of $318.84 – reached shortly after the company listed in January 2025 – illustrates the severity of the decline. In March 2026, Nasdaq issued a formal deficiency notice after the stock closed under a dollar for 30 consecutive trading days, violating Listing Rule 5550(a)(2). Diginex now has until September 21, 2026, to regain compliance by closing at or above $1.00 for at least ten consecutive sessions. If it fails, it could request an additional 180-day extension, but that hinges on meeting all other listing standards. Otherwise, delisting looms.

The Resulticks Saga Drags On

Meanwhile, the Resulticks acquisition has become a test of patience. Announced on April 16, 2026, the deal originally had a long-stop date of May 29. That was pushed to June 12, then again to today, June 30. This marks the third extension. There is no guarantee that all closing conditions will be met, as both parties still depend on factors outside their control.

The scale of the transaction is enormous relative to Diginex’s current market capitalization of roughly $25.7 million. Resulticks is being acquired for $1.5 billion and brings an estimated annual revenue of $150 million, with EBITDA between $46 million and $50 million. Strategically, the acquisition would extend Diginex’s platform from sustainability data into real-time customer engagement.

Should investors sell immediately? Or is it worth buying Diginex?

Market Skepticism Runs Deep

Investors have grown increasingly wary. The five most recent press releases related to the takeover saw Diginex’s shares decline by an average of 4.06% each time. The message is clear: the market doubts the timing and fears potential dilution from the all-stock deal. The share price now hovers near its 52-week low of $0.85.

Growth Amid Heavy Losses

Diginex’s financials tell a mixed story. Over the past twelve months, revenue grew 203%. In the first half of 2026, revenue hit $2.05 million – a 293% jump year-over-year. But the net loss ballooned by 400% to $5.81 million, underscoring the company’s unprofitability despite rapid top-line expansion.

Restructuring Continues Regardless

Resolution of the Resulticks deal will shape the next chapter, but Diginex is not standing still. The company has completed acquisitions worth over $100 million since its Nasdaq listing, most recently integrating the supply-chain solution Risk-to-Remedy. It has also appointed Carole Zibi as chief marketing officer. Internally, Diginex is consolidating four operating units – Diginex itself, Plan A.Earth, Matter DK, and The Remedy Project – into a unified technology platform.

Diginex at a turning point? This analysis reveals what investors need to know now.

Whether the Resulticks transaction finally closes today or collapses, the outcome will determine whether Diginex can sustain its ambitious growth trajectory – or must return to the drawing board.

Ad

Diginex Stock: New Analysis - 30 June

Fresh Diginex information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Diginex analysis...

en | KYG286871044 | DIGINEX | boerse | 69660765 |